← Back to Search

Radiologic Scan

LDCT Screening for Lung Cancer in High-risk Black Women

N/A

Recruiting

Led By Chi Fu Jeffrey Yang, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged >= 50 years

Self-identified Black women

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3 months

Awards & highlights

Study Summary

This trial is studying the use of LDCT in US Black women who have a history of smoking to see if it is feasible, acceptable, and effective.

Who is the study for?

This trial is for self-identified Black women aged 50 or older who have a history of smoking. There are no specific requirements on the amount they've smoked or how long ago they quit. Women with recent lung infections treated with antibiotics, a history of lung cancer, or current symptoms suggesting lung cancer (like shortness of breath, getting winded easily, chronic cough) cannot join.Check my eligibility

What is being tested?

The study is examining low-dose computed tomography (LDCT), which is a type of chest scan that uses less radiation than standard CT scans. It aims to check if this screening method is practical, acceptable and effective specifically in high-risk Black women smokers for early detection of lung cancer.See study design

What are the potential side effects?

Low-dose computed tomography itself has minimal side effects but may include exposure to low levels of radiation and potential anxiety from false positive results leading to additional testing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 50 years old or older.

Select...

I am a Black woman.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Distribution of Lung Imaging Reporting and Data System (Lung-RADS) Scores

Proportion of Enrolled Participants

Proportion of Participants Diagnosed with Invasive Lung Cancer

+1 more

Secondary outcome measures

Proportion of Participants Who Have a Complication Resulting from an Invasive Diagnostic Procedure Performed for a Positive Low-dose Computed Tomography Scan

Proportion of Participants Who Undergo Invasive Diagnostic Procedures

Trial Design

1Treatment groups

Experimental Treatment

Group I: Screening: Low-Dose Computed Tomography ScreeningExperimental Treatment1 Intervention

Participants will undergo study procedures as outlined: Complete questionnaires pre- and post- low-dose computed tomography (LDCT) test. Visit Massachusetts General Hospital facility for a LDCT screening test.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,935 Previous Clinical Trials

13,197,741 Total Patients Enrolled

Agency for Healthcare Research and Quality (AHRQ)FED

399 Previous Clinical Trials

6,821,448 Total Patients Enrolled

Chi Fu Jeffrey Yang, MDPrincipal InvestigatorMassachusetts General Hospital

Media Library

Low-dose Computed Tomography (Radiologic Scan) Clinical Trial Eligibility Overview. Trial Name: NCT05898594 — N/A

Lung Cancer Research Study Groups: Screening: Low-Dose Computed Tomography Screening

Lung Cancer Clinical Trial 2023: Low-dose Computed Tomography Highlights & Side Effects. Trial Name: NCT05898594 — N/A

Low-dose Computed Tomography (Radiologic Scan) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05898594 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there room to join this research project for interested parties?

"As indicated by clinicaltrials.gov, the recruitment for this trial has concluded as it was last updated on June 2nd 2023. A preliminary post from October 1st of that same year launched the study, however there are currently 1664 other trials enrolling patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Lung Cancer Screening in High-risk Black Women

Chi-Fu Jeffrey Yang 2023. "Lung Cancer Screening in High-risk Black Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05898594.